4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane

C103H120B2Br4F2N18O13 — CID 161096603

About 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane

4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane (PubChem CID 161096603) has the molecular formula C103H120B2Br4F2N18O13 and a molecular weight of 2197.44 g/mol. Its IUPAC name is 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane.

Molecular Properties

• Compound Name: 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane
• PubChem CID: 161096603
• Molecular Formula: C103H120B2Br4F2N18O13
• Molecular Weight: 2197.44 g/mol
• Exact Mass: 2192.62
• IUPAC Name: 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane
• SMILES: C.C.C.C.C.C.CC1(C)OB(c2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2)OC1(C)C.CC1(C)OB(c2cnc(N)c(-c3ccc(C(=O)NCc4ccccc4)c(F)c3)n2)OC1(C)C.Nc1ncc(-c2ccc(=O)[nH]c2)nc1-c1ccc(C(=O)N[C@H](CO)c2ccccc2)c(F)c1.Nc1ncc(Br)nc1-c1ccc(C(=O)N[C@H](CO)c2ccccc2)cc1.Nc1ncc(Br)nc1Br.O=c1ccc(Br)c[nH]1
• InChI: InChI=1S/C24H26BFN4O3.C24H20FN5O3.C21H26BNO4.C19H17BrN4O2.C5H4BrNO.C4H3Br2N3.6CH4/c1-23(2)24(3,4)33-25(32-23)19-14-28-21(27)20(30-19)16-10-11-17(18(26)12-16)22(31)29-13-15-8-6-5-7-9-15;25-18-10-15(22-23(26)28-12-19(29-22)16-7-9-21(32)27-11-16)6-8-17(18)24(33)30-20(13-31)14-4-2-1-3-5-14;1-20(2)21(3,4)27-22(26-20)17-12-10-16(11-13-17)19(25)23-18(14-24)15-8-6-5-7-9-15;20-16-10-22-18(21)17(24-16)13-6-8-14(9-7-13)19(26)23-15(11-25)12-4-2-1-3-5-12;6-4-1-2-5(8)7-3-4;5-2-1-8-4(7)3(6)9-2;;;;;;/h5-12,14H,13H2,1-4H3,(H2,27,28)(H,29,31);1-12,20,31H,13H2,(H2,26,28)(H,27,32)(H,30,33);5-13,18,24H,14H2,1-4H3,(H,23,25);1-10,15,25H,11H2,(H2,21,22)(H,23,26);1-3H,(H,7,8);1H,(H2,7,8);6*1H4/t;20-;18-;15-;;;;;;;;/m.111......../s1
• InChIKey: UHWLSPZHPFAMGD-FLAKVQNSSA-N
• XLogP: 17.72
• TPSA: 486.93 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 25
• Rotatable Bonds: 21
• Heavy Atoms: 142
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2197.44
LogP ≤ 5	17.72
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane?

The IUPAC name of 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane (CID 161096603) is 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane.

What is the SMILES notation for 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane?

The canonical SMILES for 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane is C.C.C.C.C.C.CC1(C)OB(c2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2)OC1(C)C.CC1(C)OB(c2cnc(N)c(-c3ccc(C(=O)NCc4ccccc4)c(F)c3)n2)OC1(C)C.Nc1ncc(-c2ccc(=O)[nH]c2)nc1-c1ccc(C(=O)N[C@H](CO)c2ccccc2)c(F)c1.Nc1ncc(Br)nc1-c1ccc(C(=O)N[C@H](CO)c2ccccc2)cc1.Nc1ncc(Br)nc1Br.O=c1ccc(Br)c[nH]1.

What is the InChIKey of 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane?

The InChIKey is UHWLSPZHPFAMGD-FLAKVQNSSA-N. The full InChI is InChI=1S/C24H26BFN4O3.C24H20FN5O3.C21H26BNO4.C19H17BrN4O2.C5H4BrNO.C4H3Br2N3.6CH4/c1-23(2)24(3,4)33-25(32-23)19-14-28-21(27)20(30-19)16-10-11-17(18(26)12-16)22(31)29-13-15-8-6-5-7-9-15;25-18-10-15(22-23(26)28-12-19(29-22)16-7-9-21(32)27-11-16)6-8-17(18)24(33)30-20(13-31)14-4-2-1-3-5-14;1-20(2)21(3,4)27-22(26-20)17-12-10-16(11-13-17)19(25)23-18(14-24)15-8-6-5-7-9-15;20-16-10-22-18(21)17(24-16)13-6-8-14(9-7-13)19(26)23-15(11-25)12-4-2-1-3-5-12;6-4-1-2-5(8)7-3-4;5-2-1-8-4(7)3(6)9-2;;;;;;/h5-12,14H,13H2,1-4H3,(H2,27,28)(H,29,31);1-12,20,31H,13H2,(H2,26,28)(H,27,32)(H,30,33);5-13,18,24H,14H2,1-4H3,(H,23,25);1-10,15,25H,11H2,(H2,21,22)(H,23,26);1-3H,(H,7,8);1H,(H2,7,8);6*1H4/t;20-;18-;15-;;;;;;;;/m.111......../s1.

What are the key properties of 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane?

4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane has a molecular weight of 2197.44 g/mol, XLogP of 17.72, 21 rotatable bonds, 13 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for 4-(3-amino-6-bromopyrazin-2-yl)-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(6-oxo-1H-pyridin-3-yl)pyrazin-2-yl]-2-fluoro-N-[(1S)-2-hydroxy-1-phenylethyl]benzamide;4-[3-amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]-N-benzyl-2-fluorobenzamide;5-bromo-1H-pyridin-2-one;3,5-dibromopyrazin-2-amine;N-[(1S)-2-hydroxy-1-phenylethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide;methane is sourced from PubChem (CID 161096603), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).